Roundtable Roundup: ER+/PR+, HER2– Breast Cancer

Publication
Article
Peers & Perspectives in OncologyDecember II, 2023
Volume 1
Issue 11
Pages: 78

Ruta D. Rao, MD, and Virginia G. Kaklamani, MD, discuss with participants the case of a patient with breast cancer who has received multiple lines of therapy and what the next steps are for her treatment.

CASE SUMMARY

Initial presentation:

  • A 56-year-old, postmenopausal woman presented with a palpable right breast mass with no clinically abnormal axillary lymph nodes.
  • Core biopsy: grade II invasive ductal carcinoma (IDC), estrogen receptor positive (ER+)/progesterone receptor positive (PR+), HER2 immunohistochemistry (IHC) score of 0, Ki-67 33%
  • Lumpectomy and sentinel lymph node (SLN) biopsy: 3.0 cm, grade 2 IDC, 2 SLN negative for malignant cells
  • 21-gene recurrence score: 27
  • She received 4 cycles of docetaxel and cyclophosphamide followed by radiation therapy and completed 5 years of adjuvant aromatase inhibitor (AI).

Three years later:

  • The patient reported right-sided abdominal pain and mild nausea.
  • CT scan of the chest/abdomen/pelvis showed 3 suspicious liver lesions (right lobe, largest 2 cm).
  • Liver biopsy showed adenocarcinoma consistent with breast primary.
    • ER+/PR+, HER2 IHC 0
  • Liver function test: within normal limits.
  • Comprehensive molecular testing from tissue biopsy showed no actionable alterations.
  • AI plus palbociclib (Ibrance) was initiated. Response: Therapy tolerated well with grade 2 neutropenia that did not require dose modification of palbociclib.

Twenty months later:

  • Follow-up imaging showed increased size of both liver nodules and 2 new lung nodules, the largest measuring 0.9 cm.
  • Her ECOG performance status was 0 and her liver enzymes were normal.

maps
polls 1
polls 2

Related Videos
Rohit Gosain, MD; Rahul Gosain, MD; and Hope Rugo, MD, presenting slides
Rohit Gosain, MD; Rahul Gosain, MD; and Hope Rugo, MD, presenting slides
Rohit Gosain, MD; Rahul Gosain, MD; and Hope Rugo, MD, presenting slides
Rohit Gosain, MD; Rahul Gosain, MD; and Hope Rugo, MD, presenting slides
Rohit Gosain, MD; Rahul Gosain, MD; and Hope Rugo, MD, presenting slides
Related Content